The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.70
Bid: 406.40
Ask: 406.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.049%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 407.70
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Update

19 Apr 2018 07:00

RNS Number : 3888L
Rentokil Initial PLC
19 April 2018
 

 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

19 April 2018

 

(£m)

 

Q1 2018

Growth

 

 

AER

AER

CER

Ongoing Revenue1

 

545.9

10.8%

15.7%

Revenue

 

550.7

-5.1%

-1.5%

 

Overview

Trading has started well across our businesses in Q1 with Ongoing Revenue increasing by 15.7%.

Organic Revenue2 Growth of 3.2% compares to Q1 2017 at 3.7%* (3.1% Reported) and Q4 2017 (3.1%). Organic growth has been affected by the ongoing impact of last September's hurricane on our operations in Puerto Rico (as previously highlighted at the time of our Preliminary results) and unseasonably cold weather in the US in March which has delayed the onset of the spring pest season. Excluding the impact of Puerto Rico, 2018 Q1 Organic growth is in line with Q1 2017.

Acquisitions have performed well contributing 12.5% to Ongoing Revenue in the first quarter.

Ongoing Revenue in Pest Control grew by 15.8% (4.7% Organic, Q1 2017: 5.6%, Q4 2017: 4.9%) with Growth markets growing by 12.4% and Emerging markets increasing by 38.2%, reflecting the strong performance of our joint venture in India.

Q1 2018 Hygiene Ongoing Revenue rose by 29.3% (1.8% Organic, Q1 2017: 3.4%, Q4 2017: -0.2%), driven by the acquisitions of Cannon Hygiene and CWS Italy.

Ongoing Revenue in our Protect & Enhance markets declined by -0.1% (-0.3 Organic, Q1 2017: -0.9%, Q4 2017: 1.0%) due to ongoing market weakness in our UK Property Care business, offset by a stronger performance from our French business.

While currency markets remain volatile, our guidance for the adverse impact of foreign exchange on profit is in the range of £10m to £15m for the year, as previously guided at the Preliminary results on 1 March 2018.

M&A 

​In the three months to 31 March 2018 we made 11 pest control acquisitions (five in North America with annualised revenues of $27m) in addition to the Cannon Hygiene businesses acquired in January. Combined annualised revenues of the 12 businesses acquired was £103.0m in the year prior to purchase. Our guidance for M&A spend remains in the range of £200m to £250m which will be funded by cash held on the balance sheet at the beginning of the year. We are encouraged about our prospects for further M&A this year and our pipeline of value-enhancing opportunities is strong.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with our performance in Q1 and we are well-positioned for another year of successful growth. We are confident that the Company will deliver a performance in line with market expectations for 2018."

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

 

 

 

 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

 

 

 

 

 

 

 

 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

 

*In Q1 2017 the Company reported Organic growth of 3.1% in Q1 but noted that excluding the businesses transferred to the Haniel JV, the Organic growth figure would have been 3.5%. We have further adjusted this number to exclude the eight French flat linen laundries sold to RLD in H2 2017, which results in a revised comparative number for Q1 2017 of 3.7%.

 

AER - actual exchange rates; CER - constant 2017 exchange rates

 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMGMDNRFGRZM
Date   Source Headline
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.